Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment

The hippocampus is involved at the onset of the neuropathological pathways leading to Alzheimer's disease (AD). Individuals with mild cognitive impairment (MCI) are at increased risk of AD. Hippocampal volume has been shown to predict which MCI subjects will convert to AD. Our aim in the present study was to produce a fully automated prognostic procedure, scalable to high throughput clinical and research applications, for the prediction of MCI conversion to AD using 3D hippocampal morphology. We used an automated analysis for the extraction and mapping of the hippocampus from structural magnetic resonance scans to extract 3D hippocampal shape morphology, and we then applied machine learning classification to predict conversion from MCI to AD. We investigated the accuracy of prediction in 103 MCI subjects (mean age 74.1 years) from the longitudinal AddNeuroMed study. Our model correctly predicted MCI conversion to dementia within a year at an accuracy of 80% (sensitivity 77%, specificity 80%), a performance which is competitive with previous predictive models dependent on manual measurements. Categorization of MCI subjects based on hippocampal morphology revealed more rapid cognitive deterioration in MMSE scores (p<0.01) and CERAD verbal memory (p<0.01) in those subjects who were predicted to develop dementia relative to those predicted to remain stable. The pattern of atrophy associated with increased risk of conversion demonstrated initial degeneration in the anterior part of the cornus ammonis 1 (CA1) hippocampal subregion. We conclude that automated shape analysis generates sensitive measurements of early neurodegeneration which predates the onset of dementia and thus provides a prognostic biomarker for conversion of MCI to AD.

[1]  C. Jack,et al.  Boosting power for clinical trials using classifiers based on multiple biomarkers , 2010, Neurobiology of Aging.

[2]  Magda Tsolaki,et al.  The AddNeuroMed framework for multi‐centre MRI assessment of Alzheimer's disease : experience from the first 24 months , 2011, International journal of geriatric psychiatry.

[3]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[4]  Nick C Fox,et al.  Automatic classification of MR scans in Alzheimer's disease. , 2008, Brain : a journal of neurology.

[5]  Kiralee M. Hayashi,et al.  Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. , 2006, Archives of neurology.

[6]  G. V. Van Hoesen,et al.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. , 1984, Science.

[7]  Anders M. Dale,et al.  A hybrid approach to the Skull Stripping problem in MRI , 2001, NeuroImage.

[8]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[9]  M. Brammer,et al.  Pattern Classification of Sad Facial Processing: Toward the Development of Neurobiological Markers in Depression , 2008, Biological Psychiatry.

[10]  N Butters,et al.  Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. , 1991, Archives of neurology.

[11]  Vladimir N. Vapnik,et al.  The Nature of Statistical Learning Theory , 2000, Statistics for Engineering and Information Science.

[12]  Paul M. Thompson,et al.  In vivo neuropathology of the hippocampal formation in AD: A radial mapping MR-based study , 2006, NeuroImage.

[13]  A. M. Dale,et al.  A hybrid approach to the skull stripping problem in MRI , 2004, NeuroImage.

[14]  Norbert Schuff,et al.  Hippocampal volume and retention in Alzheimer's disease , 2004, Journal of the International Neuropsychological Society.

[15]  C. Jack,et al.  Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease , 2009, Brain : a journal of neurology.

[16]  A. Dale,et al.  Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. , 2009, Radiology.

[17]  J. Ashburner,et al.  Prognostic and Diagnostic Potential of the Structural Neuroanatomy of Depression , 2009, PloS one.

[18]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.

[19]  Nick C Fox,et al.  The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.

[20]  Clifford R. Jack,et al.  Alzheimer's disease diagnosis in individual subjects using structural MR images: Validation studies , 2008, NeuroImage.

[21]  Cindee M. Madison,et al.  Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. , 2009, Brain : a journal of neurology.

[22]  B. Reisberg,et al.  Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment , 2006, Neurobiology of Aging.

[23]  et al.,et al.  Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline , 2008, NeuroImage.

[24]  K. Blennow,et al.  Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease , 2007, Annals of the New York Academy of Sciences.

[25]  A. Nappi,et al.  Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .

[26]  C. Davatzikos Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI , 2009, Alzheimer's & Dementia.

[27]  D. Collins,et al.  Amnestic MCI future clinical status prediction using baseline MRI features , 2010, Neurobiology of Aging.

[28]  R. Marc Lebel,et al.  In vivo quantification of hippocampal subfields using 4.7 T fast spin echo imaging , 2010, NeuroImage.

[29]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[30]  Paul M. Thompson,et al.  Direct mapping of hippocampal surfaces with intrinsic shape context , 2007, NeuroImage.

[31]  Zhuowen Tu,et al.  Auto-Context and Its Application to High-Level Vision Tasks and 3D Brain Image Segmentation , 2010, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[32]  G. Frisoni,et al.  Morphological hippocampal markers for automated detection of Alzheimer's disease and mild cognitive impairment converters in magnetic resonance images. , 2009, Journal of Alzheimer's disease : JAD.

[33]  Marti J. Anderson,et al.  Permutation Tests for Linear Models , 2001 .

[34]  D. Bennett,et al.  MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease☆ ☆ This research was supported by grants P01 AG09466 and P30 AG10161 from the National Institute on Aging, National Institutes of Health. , 2001, Neurobiology of Aging.

[35]  C. Jack,et al.  11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.

[36]  J Marshall,et al.  Cerebral blood flow in dementia. , 1975, Archives of neurology.

[37]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[38]  B. Reisberg,et al.  The Global Deterioration Scale for assessment of primary degenerative dementia. , 1982, The American journal of psychiatry.

[39]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[40]  Arthur W. Toga,et al.  Effi cient , distributed and interactive neuroimaging data analysis using the LONI Pipeline , 2009 .

[41]  Michael Weiner,et al.  and the Alzheimer’s Disease Neuroimaging Initiative* , 2007 .

[42]  N. Butters,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery , 1994, Neurology.

[43]  M. J. Wade,et al.  Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. , 2001, Archives of neurology.

[44]  A. Simmons,et al.  MRI Measures of Alzheimer's Disease and the AddNeuroMed Study , 2009, Annals of the New York Academy of Sciences.

[45]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[46]  C. Clark,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1994, Neurology.

[47]  Alexander Gammerman,et al.  Machine learning classification with confidence: Application of transductive conformal predictors to MRI-based diagnostic and prognostic markers in depression , 2011, NeuroImage.

[48]  A. Dale,et al.  Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.

[49]  Christos Davatzikos,et al.  Lack of association between 11C-PiB and longitudinal brain atrophy in non-demented older individuals , 2011, Neurobiology of Aging.

[50]  Christian Böhm,et al.  Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease , 2010, NeuroImage.

[51]  Michael I. Miller,et al.  Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly , 2005, NeuroImage.

[52]  Amity E. Green,et al.  Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls , 2009, Human brain mapping.

[53]  Xiaoying Wu,et al.  Structural and functional biomarkers of prodromal Alzheimer's disease: A high-dimensional pattern classification study , 2008, NeuroImage.

[54]  P. Scheltens,et al.  CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment , 2007, Neurobiology of Aging.

[55]  Nick C Fox,et al.  The clinical use of structural MRI in Alzheimer disease , 2010, Nature Reviews Neurology.

[56]  S Lovestone,et al.  Biomarkers for disease modification trials--the innovative medicines initiative and AddNeuroMed. , 2007, The journal of nutrition, health & aging.

[57]  Torben Hansen,et al.  Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits , 2008, BMC Medical Genetics.

[58]  T. Tombaugh,et al.  The Mini‐Mental State Examination: A Comprehensive Review , 1992, Journal of the American Geriatrics Society.

[59]  Carol Brayne,et al.  Age, neuropathology, and dementia. , 2009, The New England journal of medicine.

[60]  Karl J. Friston,et al.  Detecting Activations in PET and fMRI: Levels of Inference and Power , 1996, NeuroImage.

[61]  H. Möller,et al.  Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. , 2009, Archives of general psychiatry.

[62]  Li Shen,et al.  Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort , 2009, Current Alzheimer research.

[63]  H. Braak,et al.  Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship , 2009, Journal of neuropathology and experimental neurology.

[64]  Henrik Zetterberg,et al.  Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease , 2009, Neurobiology of Aging.

[65]  Paul M. Thompson,et al.  Mapping hippocampal and ventricular change in Alzheimer disease , 2004, NeuroImage.

[66]  M. Albert,et al.  MRI measures of entorhinal cortex vs hippocampus in preclinical AD , 2002, Neurology.

[67]  B. Turetsky,et al.  Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. , 2005, Archives of general psychiatry.

[68]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[69]  Maximilian Reiser,et al.  Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment , 2007, NeuroImage.

[70]  Paul M. Thompson,et al.  Inverse-Consistent Surface Mapping with Laplace-Beltrami Eigen-Features , 2009, IPMI.

[71]  C. Jack,et al.  Risk of dementia in MCI , 2009, Neurology.